Literature DB >> 10802024

Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area.

M D Doherty1, V M Pickel.   

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) 2A receptor antagonists are clinically effective antipsychotics that may differentially target mesocortical and mesolimbic dopaminergic neurons having partially segregated distribution in the parabrachial (PB) and paranigral (PN) ventral tegmental area (VTA). We examined the ultrastructural immunocytochemical localization of the 5-HT2A receptor in these subdivisions of rat VTA, to determine (1) the functional sites for receptor activation, and (2) cellular associations between the receptor and dopaminergic neurons identified by their content of tyrosine hydroxylase (TH). The mean area density of neuronal profiles containing 5-HT2A receptor labeling was not significantly different in the PB and PN VTA. In each region approximately 44% of the 5-HT2A labeled profiles were dendrites while the remainder were mainly axons. Dendritic 5-HT2A-immunoreactivity was often localized to membranous cytoplasmic organelles resembling smooth endoplasmic reticulum, and to more rarely to segments of the plasma membrane beneath contacts from unlabeled axon terminals. 5-HT2A labeling was also seen within the cytoplasm of a few axon initial segments and many small unmyelinated axons. Approximately 40% of the 5-HT2A-labeled dendritic profiles contained TH in either PB or PN VTA. Our results suggest that 5-HT2A receptors in VTA are largely cytoplasmic and play an equally important role in modulating dopaminergic neurons in PB and PN VTA. These results also implicate 5-HT2A receptors in the postsynaptic activation of non-dopaminergic neurons and possibly the presynaptic release from terminals of axons originating in, or passing through, these regions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10802024     DOI: 10.1016/s0006-8993(00)02062-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  45 in total

1.  Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats.

Authors:  Lara A Pockros; Nathan S Pentkowski; Sarah E Swinford; Janet L Neisewander
Journal:  Psychopharmacology (Berl)       Date:  2010-11-16       Impact factor: 4.530

Review 2.  Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects.

Authors:  Henry A Lester; Julie M Miwa; Rahul Srinivasan
Journal:  Biol Psychiatry       Date:  2012-07-06       Impact factor: 13.382

3.  A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.

Authors:  Wayne E Pratt; Kara A Clissold; Peagan Lin; Amanda E Cain; Alexa F Ciesinski; Thomas R Hopkins; Adeolu O Ilesanmi; Erin A Kelly; Zachary Pierce-Messick; Daniel S Powell; Ian A Rosner
Journal:  Brain Res       Date:  2016-07-16       Impact factor: 3.252

Review 4.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 5.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

6.  Interclass GPCR heteromerization affects localization and trafficking.

Authors:  Rudy Toneatti; Jong M Shin; Urjita H Shah; Carl R Mayer; Justin M Saunders; Miguel Fribourg; Paul T Arsenovic; William G Janssen; Stuart C Sealfon; Juan F López-Giménez; Deanna L Benson; Daniel E Conway; Javier González-Maeso
Journal:  Sci Signal       Date:  2020-10-20       Impact factor: 8.192

7.  CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling.

Authors:  Ana C Magalhaes; Kevin D Holmes; Lianne B Dale; Laetitia Comps-Agrar; Dennis Lee; Prem N Yadav; Linsay Drysdale; Michael O Poulter; Bryan L Roth; Jean-Philippe Pin; Hymie Anisman; Stephen S G Ferguson
Journal:  Nat Neurosci       Date:  2010-04-11       Impact factor: 24.884

Review 8.  Drug Interaction and Serotonin Toxicity with Opioid Use: Another Reason to Avoid Opioids in Headache and Migraine Treatment.

Authors:  Hossein Ansari; Leila Kouti
Journal:  Curr Pain Headache Rep       Date:  2016-08

9.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Authors:  Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

10.  5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.

Authors:  Lara A Pockros; Nathan S Pentkowski; Sineadh M Conway; Teresa E Ullman; Kimberly R Zwick; Janet L Neisewander
Journal:  Synapse       Date:  2012-09-11       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.